Huda Zoghbi, MD, recipient of the inaugural Mechthild Esser Nemmers Prize in Medical Science at Northwestern University, gave a presentation on her research journey studying the neurological disorder Rett syndrome.
Northwestern Medicine scientists utilized a data science approach to develop more efficient methodology that can be used to inform a wide variety of quality improvement strategies in clinical practices.
Northwestern Medicine scientists evaluated whether an RNA biosignature could distinguish if infants 60 days or younger with fever had a serious bacterial infection.
For the last decade, Ronald Ackermann, MD, MPH, has worked on implementing a method to halt diabetes that is both effective for patients and affordable for insurers. He and colleagues have focused on adapting an intervention called the Diabetes Prevention Program.
Northwestern’s biomaterials labs are developing the next generation of materials in medicine, called supramolecular biomaterials – molecules designed in a way to mimic cell structures and functions of biological signaling.
Northwestern Medicine scientists co-authored a study that identified a blood cell not normally found in the healthy brain that can invade brain tissue after status epilepticus, a type of seizure, and contributes to inflammation.
At Driskill day, students, faculty members and alumni celebrated accomplishments and research occurring in the Driskill Graduate Program in Life Sciences.
The senior project manager for the the Louis A. Simpson and Kimberly K. Querrey Biomedical Research Center shares the current progress on the construction of the university’s largest single construction project to date.
This year, the University launched a new Center for Synthetic Biology, making Northwestern one of the top three U.S. destinations for research and education in this area.
Victor Roy, an MD/PhD candidate, described the tension between pharmaceutical innovation and affordability in a recently published analysis.